For a patient with uncontrolled hypertension on amlodipine 5 mg daily, is it appropriate to add benazepril 10 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adding Benazepril to Amlodipine for Uncontrolled Hypertension

Yes, adding benazepril 10 mg to amlodipine 5 mg is highly appropriate and evidence-based for uncontrolled hypertension. This combination represents a first-line strategy supported by multiple international guidelines and robust clinical trial data.

Guideline-Based Recommendation

The combination of an ACE inhibitor (benazepril) with a calcium channel blocker (amlodipine) is explicitly recommended as a preferred dual therapy regimen across major hypertension guidelines 1, 2, 3. The 2024 ESC guidelines specifically recommend that combination BP-lowering treatment using a RAS blocker (ACE inhibitor or ARB) with a dihydropyridine CCB is preferred for most patients with confirmed hypertension 3.

The 2020 ISH guidelines provide a clear treatment algorithm: for non-Black patients with uncontrolled hypertension, the progression is to add a dihydropyridine CCB to an ACE inhibitor/ARB, or vice versa 2. Your patient is already on the CCB (amlodipine), so adding the ACE inhibitor (benazepril) follows this exact pathway.

Superior Efficacy Evidence

The landmark ACCOMPLISH trial provides the strongest evidence for this specific combination 4, 5. This study of 11,506 high-risk hypertensive patients demonstrated that benazepril-amlodipine combination was superior to benazepril-hydrochlorothiazide, reducing cardiovascular events by 20% (HR 0.80; 95% CI 0.72-0.90) 4, 5. Notably, 74% of patients achieved BP control <140/90 mmHg with this combination 5.

Multiple randomized controlled trials confirm that amlodipine/benazepril combination therapy produces significantly greater BP reductions than either monotherapy:

  • Greater reductions in sitting diastolic BP compared to amlodipine alone (p<0.03) or benazepril alone (p<0.001) 6
  • Response rates of 66-87% with combination therapy versus 38-50% with monotherapy 6, 7
  • 24-hour BP control maintained with combination therapy, unlike monotherapy 7

Dosing Considerations

The FDA-approved starting dose of benazepril is 10 mg once daily for patients not on diuretics 8, which matches your proposed regimen. This can be titrated to 20-40 mg daily if needed for BP control 8. The amlodipine 5 mg dose can also be increased to 10 mg if necessary 9.

Consider using a single-pill combination if available, as the 2024 ESC guidelines strongly recommend fixed-dose combinations to improve adherence 3. The 2018 Canadian guidelines similarly emphasize that single-pill combinations promote better adherence and reduce side effects 1.

Practical Algorithm

  1. Add benazepril 10 mg once daily to the current amlodipine 5 mg regimen
  2. Reassess BP after 2-4 weeks (guidelines recommend achieving target within 3 months) 2
  3. If BP remains uncontrolled:
    • First option: Increase benazepril to 20 mg daily 8
    • Second option: Increase amlodipine to 10 mg daily 9
    • Third option: Add a thiazide-like diuretic (chlorthalidone or indapamide preferred) 1, 4

Important Caveats

  • Monitor serum potassium and creatinine within 2-4 weeks of starting benazepril, as ACE inhibitors can cause hyperkalemia and affect renal function 1, 8
  • Avoid this combination if the patient has bilateral renal artery stenosis, pregnancy, or history of angioedema 8
  • The combination may reduce pedal edema compared to amlodipine monotherapy (1.7% vs 4.5% incidence) 6, 7, which is an additional benefit
  • Cough occurs in approximately 11% of patients on ACE inhibitor combinations 10; if intolerable, substitute an ARB
  • Do not combine benazepril with an ARB - this combination is explicitly not recommended 1, 11, 3

The evidence overwhelmingly supports your proposed approach. This combination addresses uncontrolled hypertension through complementary mechanisms and has proven cardiovascular outcome benefits.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.